from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0072/-

LFCtreatmentdescriptionclass of inhibitor

-0.111

Amikacinug/mL Amikacintranslation

0.085

Cap5-10ug/mL Capreomycintranslation

-0.506

Rox10-50 ug/mL Roxithromycintranslation

0.184

SM2-5 ug/mL Streptomycintranslation

0.209

Tet5-10 ug/mL Tetracyclinetranslation

1.233

Rif0.2-5ug/mL Rifampicintranscription

0.666

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.170

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.892

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.348

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.006

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.147

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.252

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.628

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.306

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.409

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.085

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.262

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-2.004

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.017

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.887

KCN5-20 ug/mL Potassium cyaniderespiration

-0.596

NaN30.2-2 mM Sodium aziderespiration

0.044

Nigericin50 uM Nigericinrespiration

0.640

TRC10-150 ug/mL Triclosanrespiration

-0.833

TRZ10-25 ug/mL Thioridazinerespiration

-2.168

Valinomycin0.5-10 uM Valinomycinrespiration

0.177

ZnSO42 mM ZnSO4respiration

0.286

menadione6-10 ug/mL Menadionerespiration

-0.356

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.603

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.030

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.530

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.089

NRP_1Non-replicating persistence stage 1dosRassociated

0.506

Amp0.2mg/mL AmpicillincellWall

0.195

Cephalexin20-100 ug/mL CephalexincellWall

0.511

Cerulenin0.32-5 ug/mL CerulenincellWall

1.144

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.851

EMB10-20 ug/mL EthambutolcellWall

0.178

Eta12-40 ug/mL EthionamidecellWall

0.273

INH0.2-0.4 ug/mL IsoniazidcellWall

0.426

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.502

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.218

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.027

BZA0.12 mg/mL BenzamidearomaticAmides

-0.081

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.319

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.453

H2O24 mM hydrogen peroxideDNAdamaging

0.398

Levo10 ug/mL LevofloxacinDNAdamaging

0.835

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.724

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.034

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.810

UVUV-irradiationDNAdamaging

-0.298

ARP41-4 ug/mL Antitubercular compound ARP4?

0.096

Antimycin12.5-50 ug/mL Antimycin A?

-0.137

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.126

PA_110-50 ug/mL Antitubercular compound PA-1?

0.468

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.391

PA8240.2-2 ug/mL PA-824?

-1.618

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.419

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.003

Verapamil50 uM Verapamil?

0.043

mercaptoethanol2 mM 2-Mercaptoethanol?

0.072

methoxatin10-20 ug/mL Methoxatin?